Factors Predicting Hostility in Outpatients With Schizophrenia 36-Month Results From the SOHO Study

被引:9
|
作者
Ochoa, Susana [1 ]
Suarez, David [1 ,2 ]
Novick, Diego [3 ]
Arranz, Belen [1 ]
Roca, Mercedes [1 ]
Bano, Vicente [1 ]
Maria Haro, Josep [1 ,4 ]
机构
[1] CIBERSAM, Barcelona 08830, Spain
[2] CIBERSAM, Fundacio St Joan de Deu, Barcelona 08830, Spain
[3] Eli Lilly & Co, Hlth Outcomes Res, Windlesham, Surrey, England
[4] Univ Barcelona, Fac Med, Barcelona 7, Spain
关键词
Schizophrenia; hostility; psychopathology; medication compliance; extrapyramidal effects; VIOLENT BEHAVIOR; OVERT AGGRESSION; INPATIENTS; CLOZAPINE; SYMPTOMS; RISPERIDONE; OLANZAPINE; DISORDER;
D O I
10.1097/NMD.0b013e31829480b0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This analysis explored the prevalence, incidence, and predictors of hostility in the European Schizophrenia Outpatient Health Outcomes (EU-SOHO) study. Data were collected at baseline and up to 36 months on the presence of hostility, clinical course and severity, medication compliance, side effects, substance/alcohol abuse, and being a crime survivor. Regression models were fitted to test the association between predictors and the presence of hostility. Hostility prevalence in the 6 months before baseline was 27.9%, and the incidence at 3 years was 14.0%. Variables related to hostility during follow-up were age, male sex, alcohol/substance abuse, tardive dyskinesia, extrapyramidal symptoms, cognitive impairment, noncompliance, and hospitalization. Being a crime survivor, being married, not living independently, and not being in paid employment were associated with hostility at baseline. Clinical and social variables are related to hostility in schizophrenia. Extrapyramidal symptoms and tardive dyskinesia, alcohol/substance abuse, cognitive impairment, medication noncompliance, and hospitalizations are predictors of future hostility.
引用
收藏
页码:464 / 470
页数:7
相关论文
共 50 条
  • [1] Recovery in the outpatient setting: 36-month results from the Schizophrenia Outpatients Health Outcomes (SOHO) study
    Novick, Diego
    Haro, Josep Maria
    Suarez, David
    Vieta, Eduard
    Naber, Dieter
    SCHIZOPHRENIA RESEARCH, 2009, 108 (1-3) : 223 - 230
  • [2] Clinical consequences of switching from olanzapine to risperidone and vice versa in outpatients with schizophrenia: 36-month results from the worldwide schizophrenia outpatients health outcomes (W-SOHO) study
    Hong, Jihyung
    Novick, Diego
    Brugnoli, Roberto
    Karagianis, Jamie
    Dossenbach, Martin
    Haro, Josep Maria
    BMC PSYCHIATRY, 2012, 12
  • [3] Clinical consequences of switching from olanzapine to risperidone and vice versa in outpatients with schizophrenia: 36-month results from the worldwide schizophrenia outpatients health outcomes (W-SOHO) study
    Jihyung Hong
    Diego Novick
    Roberto Brugnoli
    Jamie Karagianis
    Martin Dossenbach
    Josep Maria Haro
    BMC Psychiatry, 12
  • [4] Antipsychotic treatment discontinuation in previously untreated patients with schizophrenia: 36-month results from the SOHO study
    Maria Haro, Josep
    Novick, Diego
    Suarez, David
    Roca, Mercedes
    JOURNAL OF PSYCHIATRIC RESEARCH, 2008, 43 (03) : 265 - 273
  • [5] Tolerability of outpatient antipsychotic treatment: 36-month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study
    Novick, Diego
    Maria Haro, Josep
    Perrin, Elena
    Suarez, David
    Texeira, Joao Marques
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 (08) : 542 - 550
  • [6] Clinical consequences of switching antipsychotic drugs in outpatients with schizophrenia: 36-month results from the European Schizophrenia Outpatient Health Outcomes study
    Novick, Diego
    Maria Haro, Josep
    Suarez, David
    Marques-Teixeira, Joao
    Naber, Dieter
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2008, 23 (04) : 203 - 208
  • [7] The European Schizophrenia Outpatient Health Outcomes Study: Effectiveness results of the French cohort of schizophrenic outpatients over a 36-month follow-up
    Gasquet, I.
    Chartier, F.
    Tcherny-Lessenot, S.
    Lepine, J. -P
    REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE, 2009, 57 (01): : 25 - 32
  • [8] Effectiveness of antipsychotic treatment for schizophrenia: 6-month results of the Pan-European Schizophrenia Outpatient Health Outcomes (SOHO) study
    Haro, JM
    Edgell, ET
    Novick, D
    Alonso, J
    Kennedy, L
    Jones, PB
    Ratcliffe, M
    Breier, A
    ACTA PSYCHIATRICA SCANDINAVICA, 2005, 111 (03) : 220 - 231
  • [9] Use of concomitant medication with antipsychotic treatment in outpatients with schizophrenia: Results from the European Schizophrenia Outpatients Health Outcomes (SOHO) study
    Novick, D
    Bousono, M
    Suarez, D
    Olivares, JM
    Montejo, AL
    Haro, JM
    Edgell, ET
    Ratcliffe, M
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2005, 29 (06) : 970 - 980
  • [10] Remission in the outpatient care of schizophrenia: 3-Year results from the Schizophrenia Outpatients Health Outcomes (SOHO) Study in France
    Gasquet, Isabelle
    Haro, Josep Maria
    Tcherny-Lessenot, Stephanie
    Chartier, Florence
    Lepine, Jean-Pierre
    EUROPEAN PSYCHIATRY, 2008, 23 (07) : 491 - 496